Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Sep;1(3):145-147.
doi: 10.1007/s41669-017-0028-1.

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

Sabine Vogler  1 , Kenneth R Paterson  2
Affiliations
Editorial

Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

Sabine Vogler et al. Pharmacoecon Open. 2017 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Funding

No funding was received for writing this article.

Conflict of interest

SV and KP have no conflicts of interest to declare. All authors submitted a signed conflicts of interest disclosure form.

References

    1. Kanavos P, Vandoros S, Irwin R, Nicod E, Casson M. Differences in costs of and access to pharmaceutical products in the EU. Brussels: European Parliament; 2011.
    1. Vogler S, Lepuschütz L, Schneider P, Stühlinger V. Study on enhanced cross-country coordination in the area of pharmaceutical product pricing. Luxembourg: Gesundheit Österreich Forschungs- und Planungs GmbH; Publications Office of the European Commission; 2016.
    1. Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, et al. Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis. PLoS Med. 2016;13(5):e1002032. doi: 10.1371/journal.pmed.1002032. - DOI - PMC - PubMed
    1. Carone G, Schwierz C, Xavier A. Cost-containment policies in public pharmaceutical spending in the EU. Brussels: European Commission, Directorate-General for Economics and Financial Afairs; 2012.
    1. Fojo T, Grady C. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. J Natl Cancer Inst. 2009;101(15):1044–1048. doi: 10.1093/jnci/djp177. - DOI - PMC - PubMed

Publication types

LinkOut - more resources